Pain Perception and the Autonomic Nervous System
Launched by SCHWEINHARDT PETRA · Oct 30, 2024
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how our bodies sense and process pain, particularly looking at a part of the nervous system called the autonomic nervous system. Researchers will apply heat and pressure to the skin and measure how participants react to these sensations, including their heart rate, breathing, and sweat response. They will also assess how the spinal cord responds to electrical stimulation and gather information through questionnaires.
To participate in this study, you need to be between 18 and 40 years old and in good general health. Unfortunately, those with major medical conditions, chronic pain, or certain lifestyle habits (like high alcohol or caffeine consumption) won't be eligible. If you join the study, you can expect to engage in various tests that will help researchers understand the relationship between pain and the autonomic nervous system. Remember, this study is not yet recruiting participants, so there will be more information to come!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Over 18 and below 40 years of age
- • 2. Good general health
- • 3. Able to give informed consent
- Exclusion Criteria:
- • 1. Any major medical or psychiatric condition (e.g. heart disease, diabetes, autoimmune disorders, infectious diseases, major depressive disorder), any chronic pain condition, any respiratory problems, any acute pain at time of study
- • 2. Inability to follow study instructions, e.g. due to language problems
- • 3. Pregnancy (female participants will be asked if pregnancy could be possible)
- • 4. Increased alcohol (\>2 (for women)/4 (for men) standard glasses per day or \>5 (for women)/4 (for men) glasses at least once a month within a few hours) or caffeine consumption (≥ 400mg per day)
- • 5. Consumption of alcohol, drugs, analgesics within the last 24 h
- • 6. Consumption of more than 100 mg of caffeine within the last 8 h
- • 7. Scar tissue or generally reduced sensitivity in the designated testing site areas
- • 8. Shoe size \< 38 (if experiment is conducted at the feet)
- • 9. History of cardiovascular disease or carotid artery disease
- • 10. Medication or Substances inferring with the autonomic nervous system or with pain sensitivity (e.g. Benzodiazepines, Nicotine)
About Schweinhardt Petra
Schweinhardt Petra is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous study design and ethical standards, the organization collaborates with healthcare professionals and research institutions to conduct high-quality clinical trials across various therapeutic areas. Schweinhardt Petra prioritizes patient safety and data integrity, leveraging cutting-edge methodologies and technologies to ensure that its studies contribute meaningful insights to the medical community and support the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Petra Schweinhardt, PhD, M Chiro Med
Principal Investigator
Balgrist University Hospital, University of Zurich, Zurich, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported